Medical Care
Global CAR-T Therapy Market Research Report 2025
- Nov 18, 25
- ID: 507429
- Pages: 78
- Figures: 72
- Views: 25
This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy.
The CAR-T Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Bristol Myers Squibb
Johnson & Johnson (Legend Biotech)
Fosun Kairos
ISAO Bio
JW (Cayman) Therapeutics
CARsgen Therapeutics
Juventas Cell Therapy
Hrain Biotechnology Co
Segment by Type
Single Target
Multiple Targets
Segment by Source
Autologous
Allogeneic
Segment by Generation
First Generation
Second Generation
Third Generation
Fourth Generation
Segment by Application
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Source etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The CAR-T Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Bristol Myers Squibb
Johnson & Johnson (Legend Biotech)
Fosun Kairos
ISAO Bio
JW (Cayman) Therapeutics
CARsgen Therapeutics
Juventas Cell Therapy
Hrain Biotechnology Co
Segment by Type
Single Target
Multiple Targets
Segment by Source
Autologous
Allogeneic
Segment by Generation
First Generation
Second Generation
Third Generation
Fourth Generation
Segment by Application
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Source etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Target
1.2.3 Multiple Targets
1.3 Market by Source
1.3.1 Global CAR-T Therapy Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.4 Market by Generation
1.4.1 Global CAR-T Therapy Market Size Growth Rate by Generation: 2020 VS 2024 VS 2031
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.4.5 Fourth Generation
1.5 Market by Application
1.5.1 Global CAR-T Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Acute Lymphocytic Leukemia
1.5.3 Diffuse Large B Cell Lymphoma
1.5.4 Follicular Lymphoma
1.5.5 Chronic Lymphocytic Leukemia
1.5.6 Multiple Myeloma
1.5.7 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Therapy Market Perspective (2020-2031)
2.2 Global CAR-T Therapy Growth Trends by Region
2.2.1 Global CAR-T Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-T Therapy Historic Market Size by Region (2020-2025)
2.2.3 CAR-T Therapy Forecasted Market Size by Region (2026-2031)
2.3 CAR-T Therapy Market Dynamics
2.3.1 CAR-T Therapy Industry Trends
2.3.2 CAR-T Therapy Market Drivers
2.3.3 CAR-T Therapy Market Challenges
2.3.4 CAR-T Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Therapy Players by Revenue
3.1.1 Global Top CAR-T Therapy Players by Revenue (2020-2025)
3.1.2 Global CAR-T Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-T Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-T Therapy Revenue
3.4 Global CAR-T Therapy Market Concentration Ratio
3.4.1 Global CAR-T Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Therapy Revenue in 2024
3.5 Global Key Players of CAR-T Therapy Head office and Area Served
3.6 Global Key Players of CAR-T Therapy, Product and Application
3.7 Global Key Players of CAR-T Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Therapy Breakdown Data by Type
4.1 Global CAR-T Therapy Historic Market Size by Type (2020-2025)
4.2 Global CAR-T Therapy Forecasted Market Size by Type (2026-2031)
5 CAR-T Therapy Breakdown Data by Application
5.1 Global CAR-T Therapy Historic Market Size by Application (2020-2025)
5.2 Global CAR-T Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-T Therapy Market Size (2020-2031)
6.2 North America CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-T Therapy Market Size by Country (2020-2025)
6.4 North America CAR-T Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Therapy Market Size (2020-2031)
7.2 Europe CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-T Therapy Market Size by Country (2020-2025)
7.4 Europe CAR-T Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Therapy Market Size (2020-2031)
8.2 Asia-Pacific CAR-T Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-T Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-T Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CAR-T Therapy Market Size (2020-2031)
9.2 Latin America CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-T Therapy Market Size by Country (2020-2025)
9.4 Latin America CAR-T Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Therapy Market Size (2020-2031)
10.2 Middle East & Africa CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-T Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-T Therapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences CAR-T Therapy Introduction
11.1.4 Gilead Sciences Revenue in CAR-T Therapy Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis CAR-T Therapy Introduction
11.2.4 Novartis Revenue in CAR-T Therapy Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Therapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Details
11.4.2 Johnson & Johnson (Legend Biotech) Business Overview
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Therapy Introduction
11.4.4 Johnson & Johnson (Legend Biotech) Revenue in CAR-T Therapy Business (2020-2025)
11.4.5 Johnson & Johnson (Legend Biotech) Recent Development
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Details
11.5.2 Fosun Kairos Business Overview
11.5.3 Fosun Kairos CAR-T Therapy Introduction
11.5.4 Fosun Kairos Revenue in CAR-T Therapy Business (2020-2025)
11.5.5 Fosun Kairos Recent Development
11.6 ISAO Bio
11.6.1 ISAO Bio Company Details
11.6.2 ISAO Bio Business Overview
11.6.3 ISAO Bio CAR-T Therapy Introduction
11.6.4 ISAO Bio Revenue in CAR-T Therapy Business (2020-2025)
11.6.5 ISAO Bio Recent Development
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Details
11.7.2 JW (Cayman) Therapeutics Business Overview
11.7.3 JW (Cayman) Therapeutics CAR-T Therapy Introduction
11.7.4 JW (Cayman) Therapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.7.5 JW (Cayman) Therapeutics Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR-T Therapy Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Details
11.9.2 Juventas Cell Therapy Business Overview
11.9.3 Juventas Cell Therapy CAR-T Therapy Introduction
11.9.4 Juventas Cell Therapy Revenue in CAR-T Therapy Business (2020-2025)
11.9.5 Juventas Cell Therapy Recent Development
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Details
11.10.2 Hrain Biotechnology Co Business Overview
11.10.3 Hrain Biotechnology Co CAR-T Therapy Introduction
11.10.4 Hrain Biotechnology Co Revenue in CAR-T Therapy Business (2020-2025)
11.10.5 Hrain Biotechnology Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Target
1.2.3 Multiple Targets
1.3 Market by Source
1.3.1 Global CAR-T Therapy Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.4 Market by Generation
1.4.1 Global CAR-T Therapy Market Size Growth Rate by Generation: 2020 VS 2024 VS 2031
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.4.5 Fourth Generation
1.5 Market by Application
1.5.1 Global CAR-T Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Acute Lymphocytic Leukemia
1.5.3 Diffuse Large B Cell Lymphoma
1.5.4 Follicular Lymphoma
1.5.5 Chronic Lymphocytic Leukemia
1.5.6 Multiple Myeloma
1.5.7 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Therapy Market Perspective (2020-2031)
2.2 Global CAR-T Therapy Growth Trends by Region
2.2.1 Global CAR-T Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-T Therapy Historic Market Size by Region (2020-2025)
2.2.3 CAR-T Therapy Forecasted Market Size by Region (2026-2031)
2.3 CAR-T Therapy Market Dynamics
2.3.1 CAR-T Therapy Industry Trends
2.3.2 CAR-T Therapy Market Drivers
2.3.3 CAR-T Therapy Market Challenges
2.3.4 CAR-T Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Therapy Players by Revenue
3.1.1 Global Top CAR-T Therapy Players by Revenue (2020-2025)
3.1.2 Global CAR-T Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-T Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-T Therapy Revenue
3.4 Global CAR-T Therapy Market Concentration Ratio
3.4.1 Global CAR-T Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Therapy Revenue in 2024
3.5 Global Key Players of CAR-T Therapy Head office and Area Served
3.6 Global Key Players of CAR-T Therapy, Product and Application
3.7 Global Key Players of CAR-T Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Therapy Breakdown Data by Type
4.1 Global CAR-T Therapy Historic Market Size by Type (2020-2025)
4.2 Global CAR-T Therapy Forecasted Market Size by Type (2026-2031)
5 CAR-T Therapy Breakdown Data by Application
5.1 Global CAR-T Therapy Historic Market Size by Application (2020-2025)
5.2 Global CAR-T Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-T Therapy Market Size (2020-2031)
6.2 North America CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-T Therapy Market Size by Country (2020-2025)
6.4 North America CAR-T Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Therapy Market Size (2020-2031)
7.2 Europe CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-T Therapy Market Size by Country (2020-2025)
7.4 Europe CAR-T Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Therapy Market Size (2020-2031)
8.2 Asia-Pacific CAR-T Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-T Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-T Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CAR-T Therapy Market Size (2020-2031)
9.2 Latin America CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-T Therapy Market Size by Country (2020-2025)
9.4 Latin America CAR-T Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Therapy Market Size (2020-2031)
10.2 Middle East & Africa CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-T Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-T Therapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences CAR-T Therapy Introduction
11.1.4 Gilead Sciences Revenue in CAR-T Therapy Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis CAR-T Therapy Introduction
11.2.4 Novartis Revenue in CAR-T Therapy Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Therapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Details
11.4.2 Johnson & Johnson (Legend Biotech) Business Overview
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Therapy Introduction
11.4.4 Johnson & Johnson (Legend Biotech) Revenue in CAR-T Therapy Business (2020-2025)
11.4.5 Johnson & Johnson (Legend Biotech) Recent Development
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Details
11.5.2 Fosun Kairos Business Overview
11.5.3 Fosun Kairos CAR-T Therapy Introduction
11.5.4 Fosun Kairos Revenue in CAR-T Therapy Business (2020-2025)
11.5.5 Fosun Kairos Recent Development
11.6 ISAO Bio
11.6.1 ISAO Bio Company Details
11.6.2 ISAO Bio Business Overview
11.6.3 ISAO Bio CAR-T Therapy Introduction
11.6.4 ISAO Bio Revenue in CAR-T Therapy Business (2020-2025)
11.6.5 ISAO Bio Recent Development
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Details
11.7.2 JW (Cayman) Therapeutics Business Overview
11.7.3 JW (Cayman) Therapeutics CAR-T Therapy Introduction
11.7.4 JW (Cayman) Therapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.7.5 JW (Cayman) Therapeutics Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR-T Therapy Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Details
11.9.2 Juventas Cell Therapy Business Overview
11.9.3 Juventas Cell Therapy CAR-T Therapy Introduction
11.9.4 Juventas Cell Therapy Revenue in CAR-T Therapy Business (2020-2025)
11.9.5 Juventas Cell Therapy Recent Development
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Details
11.10.2 Hrain Biotechnology Co Business Overview
11.10.3 Hrain Biotechnology Co CAR-T Therapy Introduction
11.10.4 Hrain Biotechnology Co Revenue in CAR-T Therapy Business (2020-2025)
11.10.5 Hrain Biotechnology Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CAR-T Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Single Target
Table 3. Key Players of Multiple Targets
Table 4. Global CAR-T Therapy Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Autologous
Table 6. Key Players of Allogeneic
Table 7. Global CAR-T Therapy Market Size Growth Rate by Generation (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of First Generation
Table 9. Key Players of Second Generation
Table 10. Key Players of Third Generation
Table 11. Key Players of Fourth Generation
Table 12. Global CAR-T Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Global CAR-T Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global CAR-T Therapy Market Share by Region (2020-2025)
Table 16. Global CAR-T Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global CAR-T Therapy Market Share by Region (2026-2031)
Table 18. CAR-T Therapy Market Trends
Table 19. CAR-T Therapy Market Drivers
Table 20. CAR-T Therapy Market Challenges
Table 21. CAR-T Therapy Market Restraints
Table 22. Global CAR-T Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 23. Global CAR-T Therapy Market Share by Players (2020-2025)
Table 24. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2024)
Table 25. Ranking of Global Top CAR-T Therapy Companies by Revenue (US$ Million) in 2024
Table 26. Global 5 Largest Players Market Share by CAR-T Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 27. Global Key Players of CAR-T Therapy, Headquarters and Area Served
Table 28. Global Key Players of CAR-T Therapy, Product and Application
Table 29. Global Key Players of CAR-T Therapy, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR-T Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 32. Global CAR-T Therapy Revenue Market Share by Type (2020-2025)
Table 33. Global CAR-T Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 34. Global CAR-T Therapy Revenue Market Share by Type (2026-2031)
Table 35. Global CAR-T Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 36. Global CAR-T Therapy Revenue Market Share by Application (2020-2025)
Table 37. Global CAR-T Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 38. Global CAR-T Therapy Revenue Market Share by Application (2026-2031)
Table 39. North America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. North America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 41. North America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 42. Europe CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Europe CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Europe CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Asia-Pacific CAR-T Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 46. Asia-Pacific CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 47. Asia-Pacific CAR-T Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 48. Latin America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Latin America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 50. Latin America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 51. Middle East & Africa CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Middle East & Africa CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 53. Middle East & Africa CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 54. Gilead Sciences Company Details
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences CAR-T Therapy Product
Table 57. Gilead Sciences Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis CAR-T Therapy Product
Table 62. Novartis Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol Myers Squibb Company Details
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb CAR-T Therapy Product
Table 67. Bristol Myers Squibb Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 68. Bristol Myers Squibb Recent Development
Table 69. Johnson & Johnson (Legend Biotech) Company Details
Table 70. Johnson & Johnson (Legend Biotech) Business Overview
Table 71. Johnson & Johnson (Legend Biotech) CAR-T Therapy Product
Table 72. Johnson & Johnson (Legend Biotech) Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 73. Johnson & Johnson (Legend Biotech) Recent Development
Table 74. Fosun Kairos Company Details
Table 75. Fosun Kairos Business Overview
Table 76. Fosun Kairos CAR-T Therapy Product
Table 77. Fosun Kairos Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 78. Fosun Kairos Recent Development
Table 79. ISAO Bio Company Details
Table 80. ISAO Bio Business Overview
Table 81. ISAO Bio CAR-T Therapy Product
Table 82. ISAO Bio Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 83. ISAO Bio Recent Development
Table 84. JW (Cayman) Therapeutics Company Details
Table 85. JW (Cayman) Therapeutics Business Overview
Table 86. JW (Cayman) Therapeutics CAR-T Therapy Product
Table 87. JW (Cayman) Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 88. JW (Cayman) Therapeutics Recent Development
Table 89. CARsgen Therapeutics Company Details
Table 90. CARsgen Therapeutics Business Overview
Table 91. CARsgen Therapeutics CAR-T Therapy Product
Table 92. CARsgen Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 93. CARsgen Therapeutics Recent Development
Table 94. Juventas Cell Therapy Company Details
Table 95. Juventas Cell Therapy Business Overview
Table 96. Juventas Cell Therapy CAR-T Therapy Product
Table 97. Juventas Cell Therapy Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 98. Juventas Cell Therapy Recent Development
Table 99. Hrain Biotechnology Co Company Details
Table 100. Hrain Biotechnology Co Business Overview
Table 101. Hrain Biotechnology Co CAR-T Therapy Product
Table 102. Hrain Biotechnology Co Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 103. Hrain Biotechnology Co Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. CAR-T Therapy Picture
Figure 2. Global CAR-T Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Therapy Market Share by Type: 2024 VS 2031
Figure 4. Single Target Features
Figure 5. Multiple Targets Features
Figure 6. Global CAR-T Therapy Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 7. Autologous Features
Figure 8. Allogeneic Features
Figure 9. Global CAR-T Therapy Market Size Comparison by Generation (2020-2031) & (US$ Million)
Figure 10. First Generation Features
Figure 11. Second Generation Features
Figure 12. Third Generation Features
Figure 13. Fourth Generation Features
Figure 14. Global CAR-T Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 15. Global CAR-T Therapy Market Share by Application: 2024 VS 2031
Figure 16. Acute Lymphocytic Leukemia Case Studies
Figure 17. Diffuse Large B Cell Lymphoma Case Studies
Figure 18. Follicular Lymphoma Case Studies
Figure 19. Chronic Lymphocytic Leukemia Case Studies
Figure 20. Multiple Myeloma Case Studies
Figure 21. Other Case Studies
Figure 22. CAR-T Therapy Report Years Considered
Figure 23. Global CAR-T Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global CAR-T Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global CAR-T Therapy Market Share by Region: 2024 VS 2031
Figure 26. Global CAR-T Therapy Market Share by Players in 2024
Figure 27. Global CAR-T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by CAR-T Therapy Revenue in 2024
Figure 29. North America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America CAR-T Therapy Market Share by Country (2020-2031)
Figure 31. United States CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe CAR-T Therapy Market Share by Country (2020-2031)
Figure 35. Germany CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific CAR-T Therapy Market Share by Region (2020-2031)
Figure 43. China CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America CAR-T Therapy Market Share by Country (2020-2031)
Figure 51. Mexico CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa CAR-T Therapy Market Share by Country (2020-2031)
Figure 55. Israel CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Gilead Sciences Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 61. Johnson & Johnson (Legend Biotech) Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 62. Fosun Kairos Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 63. ISAO Bio Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 64. JW (Cayman) Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 65. CARsgen Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 66. Juventas Cell Therapy Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 67. Hrain Biotechnology Co Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global CAR-T Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Single Target
Table 3. Key Players of Multiple Targets
Table 4. Global CAR-T Therapy Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Autologous
Table 6. Key Players of Allogeneic
Table 7. Global CAR-T Therapy Market Size Growth Rate by Generation (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of First Generation
Table 9. Key Players of Second Generation
Table 10. Key Players of Third Generation
Table 11. Key Players of Fourth Generation
Table 12. Global CAR-T Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Global CAR-T Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global CAR-T Therapy Market Share by Region (2020-2025)
Table 16. Global CAR-T Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global CAR-T Therapy Market Share by Region (2026-2031)
Table 18. CAR-T Therapy Market Trends
Table 19. CAR-T Therapy Market Drivers
Table 20. CAR-T Therapy Market Challenges
Table 21. CAR-T Therapy Market Restraints
Table 22. Global CAR-T Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 23. Global CAR-T Therapy Market Share by Players (2020-2025)
Table 24. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2024)
Table 25. Ranking of Global Top CAR-T Therapy Companies by Revenue (US$ Million) in 2024
Table 26. Global 5 Largest Players Market Share by CAR-T Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 27. Global Key Players of CAR-T Therapy, Headquarters and Area Served
Table 28. Global Key Players of CAR-T Therapy, Product and Application
Table 29. Global Key Players of CAR-T Therapy, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR-T Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 32. Global CAR-T Therapy Revenue Market Share by Type (2020-2025)
Table 33. Global CAR-T Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 34. Global CAR-T Therapy Revenue Market Share by Type (2026-2031)
Table 35. Global CAR-T Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 36. Global CAR-T Therapy Revenue Market Share by Application (2020-2025)
Table 37. Global CAR-T Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 38. Global CAR-T Therapy Revenue Market Share by Application (2026-2031)
Table 39. North America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. North America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 41. North America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 42. Europe CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Europe CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Europe CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Asia-Pacific CAR-T Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 46. Asia-Pacific CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 47. Asia-Pacific CAR-T Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 48. Latin America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Latin America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 50. Latin America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 51. Middle East & Africa CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Middle East & Africa CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 53. Middle East & Africa CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 54. Gilead Sciences Company Details
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences CAR-T Therapy Product
Table 57. Gilead Sciences Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis CAR-T Therapy Product
Table 62. Novartis Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol Myers Squibb Company Details
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb CAR-T Therapy Product
Table 67. Bristol Myers Squibb Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 68. Bristol Myers Squibb Recent Development
Table 69. Johnson & Johnson (Legend Biotech) Company Details
Table 70. Johnson & Johnson (Legend Biotech) Business Overview
Table 71. Johnson & Johnson (Legend Biotech) CAR-T Therapy Product
Table 72. Johnson & Johnson (Legend Biotech) Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 73. Johnson & Johnson (Legend Biotech) Recent Development
Table 74. Fosun Kairos Company Details
Table 75. Fosun Kairos Business Overview
Table 76. Fosun Kairos CAR-T Therapy Product
Table 77. Fosun Kairos Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 78. Fosun Kairos Recent Development
Table 79. ISAO Bio Company Details
Table 80. ISAO Bio Business Overview
Table 81. ISAO Bio CAR-T Therapy Product
Table 82. ISAO Bio Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 83. ISAO Bio Recent Development
Table 84. JW (Cayman) Therapeutics Company Details
Table 85. JW (Cayman) Therapeutics Business Overview
Table 86. JW (Cayman) Therapeutics CAR-T Therapy Product
Table 87. JW (Cayman) Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 88. JW (Cayman) Therapeutics Recent Development
Table 89. CARsgen Therapeutics Company Details
Table 90. CARsgen Therapeutics Business Overview
Table 91. CARsgen Therapeutics CAR-T Therapy Product
Table 92. CARsgen Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 93. CARsgen Therapeutics Recent Development
Table 94. Juventas Cell Therapy Company Details
Table 95. Juventas Cell Therapy Business Overview
Table 96. Juventas Cell Therapy CAR-T Therapy Product
Table 97. Juventas Cell Therapy Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 98. Juventas Cell Therapy Recent Development
Table 99. Hrain Biotechnology Co Company Details
Table 100. Hrain Biotechnology Co Business Overview
Table 101. Hrain Biotechnology Co CAR-T Therapy Product
Table 102. Hrain Biotechnology Co Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 103. Hrain Biotechnology Co Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. CAR-T Therapy Picture
Figure 2. Global CAR-T Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Therapy Market Share by Type: 2024 VS 2031
Figure 4. Single Target Features
Figure 5. Multiple Targets Features
Figure 6. Global CAR-T Therapy Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 7. Autologous Features
Figure 8. Allogeneic Features
Figure 9. Global CAR-T Therapy Market Size Comparison by Generation (2020-2031) & (US$ Million)
Figure 10. First Generation Features
Figure 11. Second Generation Features
Figure 12. Third Generation Features
Figure 13. Fourth Generation Features
Figure 14. Global CAR-T Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 15. Global CAR-T Therapy Market Share by Application: 2024 VS 2031
Figure 16. Acute Lymphocytic Leukemia Case Studies
Figure 17. Diffuse Large B Cell Lymphoma Case Studies
Figure 18. Follicular Lymphoma Case Studies
Figure 19. Chronic Lymphocytic Leukemia Case Studies
Figure 20. Multiple Myeloma Case Studies
Figure 21. Other Case Studies
Figure 22. CAR-T Therapy Report Years Considered
Figure 23. Global CAR-T Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global CAR-T Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global CAR-T Therapy Market Share by Region: 2024 VS 2031
Figure 26. Global CAR-T Therapy Market Share by Players in 2024
Figure 27. Global CAR-T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by CAR-T Therapy Revenue in 2024
Figure 29. North America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America CAR-T Therapy Market Share by Country (2020-2031)
Figure 31. United States CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe CAR-T Therapy Market Share by Country (2020-2031)
Figure 35. Germany CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific CAR-T Therapy Market Share by Region (2020-2031)
Figure 43. China CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America CAR-T Therapy Market Share by Country (2020-2031)
Figure 51. Mexico CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa CAR-T Therapy Market Share by Country (2020-2031)
Figure 55. Israel CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Gilead Sciences Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 61. Johnson & Johnson (Legend Biotech) Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 62. Fosun Kairos Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 63. ISAO Bio Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 64. JW (Cayman) Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 65. CARsgen Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 66. Juventas Cell Therapy Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 67. Hrain Biotechnology Co Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232